Google DeepMind has introduced AlphaGenome Atlas, an AI-driven, searchable database for whole-genome predictions. This innovative database has carried out exhaustive calculations for a staggering 9 billion potential single-base mutations within the human genome, delivering around 27,000 predictive indicators for every single mutation. The sheer volume of its data is 30 times greater than that of the AlphaFold database. AlphaGenome Atlas is designed for effortless accessibility, enabling researchers to swiftly retrieve results by merely inputting genetic loci into a web browser, eliminating the need for coding or establishing local computing environments. The database boasts a multi-tiered, interlinked decryption framework. By merging AlphaGenome with AlphaMissense, it enhances the AVI metric to pinpoint high-risk variants, assesses the biological implications of scores, and identifies prevalent DNA patterns. In real-world scenarios, AlphaGenome Atlas has proven instrumental in pinpointing disease-causing mutations in children suffering from epilepsy and has streamlined the analysis of rare genetic variants in various populations. Furthermore, the database has been seamlessly integrated into the Google Antigravity agent platform. This development represents another major milestone for DeepMind in the realm of biological computing, building on the success of AlphaFold and heralding a new era where life sciences are transitioning from merely 'decoding life' to 'predicting life'.